MP21-10 A URINARY PROTEOMICS ANALYSIS OF PATIENTS TREATED WITH NEOADJUVANT AXITINIB FOR NON-METASTATIC CLEAR-CELL RENAL-CELL CARCINOMA: ANALYSIS FROM A PHASE II TRIAL | Zendy

AI Assistant Blog Pricing

MP21-10 A URINARY PROTEOMICS ANALYSIS OF PATIENTS TREATED WITH NEOADJUVANT AXITINIB FOR NON-METASTATIC CLEAR-CELL RENAL-CELL CARCINOMA: ANALYSIS FROM A PHASE II TRIAL

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.